Primary Percutaneous Coronary Intervention
16
0
1
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 16 trials
100.0%
+13.5% vs benchmark
13%
2 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (16)
Use of Export in Primary Percutaneous Coronary Intervention
Remote Ischemic Conditioning in Patients Undergoing Primary Percutaneous Coronary Intervention
Prognostic Value of the CALLY Index in Patients Undergoing Primary PCI
Impact of Gut Microbiota on Clinical Outcomes and Left Ventricular Remodeling After Primary Percutaneous Coronary Intervention
Relation of Total Ischemic Time to Repolarization Indices and Their Impact on Outcomes Among STEMI Patients Undergoing Primary PCI
The Effect of Cardiac Rehabilitation on Left Ventricular Remodeling in Patients Undergoing Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction
Prognostic Value of the LVOT VTI in STEMI Patients Undergoing PPCI
Thin Versus Thicker Strut Thickness Stents in Primary Percutaneous Intervention
Short Term Outcomes of Primary Percutaneous Coronary Intervention (PCI) Patients Presented with Acute Heart Failure in Assuit University Heart Hospital
Influence Of Incomplete Revascularization on Long-Term Outcomes After Primary Percutaneous Coronary Intervention (PPCI)
Biomarkers for Risk Stratification After STEMI
Prolonged Enoxaparin In Primary Percutaneous Coronary Intervention; A Pilot Pharmacodynamic Study
Prevention of Coronary Slow Flow or No-Reflow During PPCI in Patients With Acute STEMI
Verification of the Safety of Early Discharge in Patients After Acute ST-segment Myocardial Infarction
Closed Versus Open Cells Stent for Acute Myocardial Infarction
Bivalirudin/Prasugrel Versus Abciximab/Clopidogrel in Patients Presenting With STEMI